Daily non-political popular news in brief.
Shark cartilage shows no benefit as a therapeutic agent for lung cancer
06-02-2007 · EurekAlert!In the first scientific study of its kind, shark cartilage extract, AE-941 or Neovastat, has shown no benefit as a therapeutic agent when combined with chemotherapy and radiation for patients with advanced non-small cell lung cancer, according to researchers at the University of Texas M. D. Anderson Cancer Center.
Read more »
Keywords: shark, cartilage, shows, benefit, therapeutic, agent, lung, cancer, show
« Previous | Next »
Similar news on "Shark cartilage shows no benefit as a therapeutic agent for lung cancer":
- Study shows no survival benefit for CT screening for lung cancer
03-06-2007 · EurekAlert!
The first report of an international study looking at computed tomography (CT) to screen current or former smokers for lung cancer found that screening did not reduce deaths from lung cancer. Although CT screening found nearly three times as many lung cancers as predicted, the researchers found that early detection and treatment did not lead to a corresponding decrease in advanced lung cancers or a reduction in deaths from lung cancer.
Similar news · Read more »
- Blood protein detects lung cancer, even at earliest stage
09-18-2007 · EurekAlert!
Biopharmaceutical researchers have found a protein in blood they say is linked to all stages of lung cancer but which rarely shows up in the blood of people without the disease. Testing for this protein might help physicians decide whether smokers or others at high risk for lung cancer should be referred for lung imaging, say investigators, who presented their findings today in Atlanta, Ga., at the AACR's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development.
Similar news · Read more »
- Targeted, oral agent Enzastaurin shows favorable results
06-02-2007 · EurekAlert!
Enzastaurin, an investigational targeted, oral agent under development by Eli Lilly and Company, showed encouraging results in treating patients with late-stage non-small cell lung cancer (NSCLC), according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO).
Similar news · Read more »
- New radiation technique can greatly reduce painful skin burns in women with breast cancer
11-06-2006 · EurekAlert!
Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia. The study is the first of its kind to show how recent dramatic improvements in radiation treatments directly benefit patients.
Similar news · Read more »
- Talcum powder stunts growth of lung tumors
06-06-2007 · EurekAlert!
University of Florida researchers say talc is an exciting new therapeutic agent for a cancer largely considered incurable. Talc stimulates healthy cells to produce endostatin, a hormone considered valuable for treating metastatic lung cancer.
Similar news · Read more »
- Antibiotic Inhibits Cancer Gene Activity
10-02-2006 · ScienceDaily
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine.
Similar news · Read more »
- VEGF Trap shows activity in patients with advanced ovarian cancer
06-02-2007 · EurekAlert!
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. The findings, which are being presented today at the American Society of Clinical Oncology’s annual meeting, may indicate a role for this targeted therapy in women with ovarian cancer who have exhausted all other options.
Similar news · Read more »
- Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer
11-01-2007 · EurekAlert!
A Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer.
Similar news · Read more »
- Shrinkage of prostate led to overestimation of cancer risk in trial
09-12-2007 · EurekAlert!
Reanalysis of data from the Prostate Cancer Prevention Trial of a chemopreventive agent for prostate cancer shows that the excess prevalence of high-grade prostate cancer in the drug-treated group may be attributable to shrinkage of the prostate at the time of biopsy.
Similar news · Read more »
- OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
06-02-2007 · EurekAlert!
The study showed that sipuleucel-T did not significantly delay the time it took for a patient's PSA to reach a value of 3 ng/ml, the primary endpoint of the study, but it did show a prolongation in prostate-specific antigen doubling time (PSADT).
Similar news · Read more »
